[1]JournaloftheAmericanChemicalSociety,2006,vol.128,p.15072-15073
[2]Patent:EP2740491,2014,A1.Locationinpatent:Paragraph0139;0140
[3]Patent:WO2014/86942,2014,A1.Locationinpatent:Page/Pagecolumn39
[4]Patent:US6838557,2005,B1.Locationinpatent:Pagecolumn10-11
[1]CurrentPatentAssignee:INSTITUTEOFPHYSICALANDCHEMICALRESEARCH(RIKEN);OSAKAUNIVERSITY-EP2128124,2009,A1Locationinpatent:Page/Pagecolumn98
[2]Tanaka,Katsunori;Masuyama,Tatsuro;Hasegawa,Koki;Tahara,Tsuyoshi;Mizuma,Hiroshi;Wada,Yasuhiro;Watanabe,Yasuyoshi;Fukase,Koichi[AngewandteChemie-InternationalEdition,2008,vol.47,#1,p.102-105]
[1]ScientiaPharmaceutica,2008,vol.76,p.151-170
[2]Journaloflabelledcompoundsandradiopharmaceuticals,2012,vol.55,p.103-107
[3]ChemicalCommunications,2013,vol.49,p.564-566
[1]Locationinpatent:experimentalpartBanerjee,SangeetaRay;Pullambhatla,Mrudula;Byun,Youngjoo;Nimmagadda,Sridhar;Green,Gilbert;Fox,JamesJ.;Horti,Andrew;Mease,RonnieC.;Pomper,MartinG.[JournalofMedicinalChemistry,2010,vol.53,#14,p.5333-5341]
[2]CurrentPatentAssignee:THEJOHNSHOPKINSUNIVERSITY-WO2010/108125,2010,A2Locationinpatent:Page/Pagecolumn60-61
[1]CurrentPatentAssignee:TAGWORKSPHARMACEUTICALSBV-US2012/34161,2012,A1
Title: Hoppmann S, et al. Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting.Bioconjug Chem. 2011 Mar 16;22(3):413-2